Results of a UK survey of fatal anaphylaxis after oral amoxicillin
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Sir, A single high dose of oral amoxicillin has been the main antibiotic regimen recommended for the prophylaxis of endocarditis since 1982, 1 and there has been good compliance with this recommendation in the UK. 2 However, the fear that the number of deaths from anaphylaxis associated with amoxicillin prophylaxis could exceed the number of deaths from endocarditis that might be prevented from prophylaxis was one factor leading the BSAC Working Party to discontinue recommending prophylaxis for most susceptible cardiac patients undergoing dental procedures. 3 We would like to contribute information from data which should be taken into account in discussions around the risk/benefit considerations. This may be particularly appropriate now as The Department of Health has asked the National Institute for Health and Clinical Excellence (NICE) to prepare guidance on antimicrobial prophylaxis for endocarditis in patients undergoing interventional procedures and to review the risks and benefits of antibiotics. The MHRA collects information on suspected adverse drug reactions (ADRs) via the Yellow Card Scheme. The scheme was set up in 1964 and receives reports of suspected ADRs directly from healthcare professionals and more recently from patients. Healthcare professionals are requested to report ADRs to the Yellow Card Scheme, even if there is only a suspicion that a medicine may have caused the reaction, by using the yellow pages in the British National Formulary or online at http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE&nodeId=287 . It is a statutory requirement that pharmaceutical companies report suspected ADRs to the scheme. The MHRA's database contains a total of 4333 UK reports of spontaneous suspected ADRs in association with amoxicillin between 13 February 1972 and 2 May 2007. 4 There are a total of eight fatal cases of anaphylaxis; of which, five had an intravenous route of administration and in two cases, the route was unknown. There was only one case of fatal anaphylaxis in association with oral amoxicillin; this was in a female patient prescribed 250 mg orally four times daily for an unknown indication. The MHRA are not aware of any fatal cases reported with the single 3 g oral dose of amoxicillin that is recommended for prophylaxis of endocarditis in adults and none with any oral dose of amoxicillin in children. However, it is important to note that information on suspect drug dose and indication may not always be provided by the original reporter; therefore, the data must be interpreted with caution. We are not aware of any published literature case reports from the UK of fatal anaphylaxis, following oral amoxicillin prophylaxis of endocarditis. The risk of fatal anaphylaxis with penicillin has previously been estimated as about 1 in 100 000 and is greater in those receiving penicillin parenterally than orally. 5 However, the risk with other β-lactam antibiotics, including amoxicillin, is poorly documented. In recent correspondence relating to the latest BSAC guidelines to prevent endocarditis, it was suggested that there was a fatal anaphylaxis rate of 20 per million, although this was in association with ampicillin as well as amoxicillin and did not differentiate between parenteral and oral administration of these antibiotics. 6 Yellow Card data cannot be used to determine the incidence of a particular ADR as denominator data are not available, and causality is not certain. Reporting by health professionals is entirely voluntary, and not all ADRs are reported, while those received may omit relevant data, or may be confounded by other factors. Although healthcare professionals are more likely to report serious or fatal suspected ADRs than non-serious reactions, it is a fact that the reporting of ADRs for many older drugs such as amoxicillin is much lower than that for newer drugs. In addition, reporting of some ADRs may reflect elevated public profile rather than true incidence. The American Heart Association committee report about preventing endocarditis also noted that it was unaware of any reports of fatal anaphylaxis associated with the antibiotic prophylaxis of endocarditis in the USA during the last 50 years, and oral amoxicillin has also been the mainstay of the recommended regimens during the last 20 years. 7 Within the aforementioned limitations of spontaneous reporting for estimating the frequency of serious adverse reactions, the reporting rate from data available in the Yellow Card Scheme for oral amoxicillin is extremely low given the recently quoted risk of death from anaphylaxis in recent correspondence relating to the latest BSAC guidelines. 6 Although it is not possible to easily obtain usage data for oral amoxicillin for the last 35 years, usage data for the last 5 years suggest that there were approximately 100 million treatment courses of oral amoxicillin during this time period. 8 Although it is not possible to infer an incidence rate from the reporting rate, the rec
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A maternal death due to an abortion in the US is as rare as a death due to a shot of penicillin, less than 1 per 100,000 procedures [18].”
From Navigating the crisis landscape: engaging the ministry of health and United Nations agencies to make abortion care available to Rohingya refugees (2020) · cites this paper as [18]
Citations
Cites
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Gould, F. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl121 · Cited by 398
Kaufman, D. W., & Anaphylaxis, T. I. C. S. O. S. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.822 · Cited by 121 · cited 1×
“The risk of fatal anaphylaxis with penicillin has previously been estimated as about 1 in 100 000 and is greater in those receiving penicillin parenterally than orally.(5) However, the risk with other b-lactam antibiotics, including amoxicillin, is poorly documented.”
BackgroundThe antibiotic prophylaxis of infective endocarditis
CAWSON, R. A. (1983) · BDJ · doi:10.1038/sj.bdj.4805034 · Cited by 72
Antibiotic prophylaxis of infective endocarditis in the United Kingdom and Europe
Shanson, D. C. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.suppl_a.119 · Cited by 28 · cited 1×
“Sir, A single high dose of oral amoxicillin has been the main antibiotic regimen recommended for the prophylaxis of endocarditis since 1982,(1) and there has been good compliance with this recommendation in the UK.(2) However, the fear that the number of deaths from anaphylaxis associated with amoxicillin prophylaxis…”
BackgroundSelf-citationGould, F. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl299 · Cited by 27 · cited 2×
“In recent correspondence relating to the latest BSAC guidelines to prevent endocarditis, it was suggested that there was a fatal anaphylaxis rate of 20 per million, although this was in association with ampicillin as well as amoxicillin and did not differentiate between parenteral and oral administration of these anti…”
Background
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“However, the lethal risk of anaphylaxis seems very low when using oral amoxicillin.(21) † Widespread use of antibiotics may result in the emergence of resistant microorganisms.”
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Evaluation and Management of Penicillin Allergy: A Review
Shenoy, E. S., Macy, E., Rowe, T., & Blumenthal, K. G. (2019) · JAMA · doi:10.1001/jama.2018.19283 · Cited by 830
“Among 100 million people exposed to oral amoxicillin between 1972 and 2007 in the United Kingdom, only 1 death after anaphylaxis in association with oral amoxicillin was identified.(15) Most reports of penicillin allergy describe an unknownor cutaneous reaction.”
BackgroundATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
“[39] There was one fatal amoxicillin reaction in the UK during the period from 1972 to 2007.[37] The changing epidemiology of IgE-mediated penicillin allergy might be attributed to newer, less allergenic formulations and changes in administration route.”
BackgroundManagement of allergy to penicillins and other beta‐lactams
Mirakian, R., Leech, S. C., Krishna, M. T., Richter, A. G., Huber, P. A. J., Farooque, S., Khan, N., Pirmohamed, M., Clark, A. T., & Nasser, S. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12468 · Cited by 285
Castells, M., Khan, D. A., & Phillips, E. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807761 · Cited by 270
Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
Glenny, A.-M., Oliver, R., Roberts, G. J., Hooper, L., & Worthington, H. V. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003813.pub4 · Cited by 236
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · Kardiologia Polska · doi:10.5603/kp.2015.0227 · Cited by 165
Macy, E., & Contreras, R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.062 · Cited by 153
Prophylaxis against infective endocarditis
Richards, D. (2008) · Evidence-Based Dentistry · doi:10.1038/sj.ebd.6400577 · Cited by 120
Mustafa, S. S., Conn, K. M., & Ramsey, A. C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.037 · Cited by 128
Mori, F., Cianferoni, A., Barni, S., Pucci, N., Rossi, M. E., & Novembre, E. M. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.11.001 · Cited by 99
Evaluating Penicillin Allergies Without Skin Testing
Banks, T. A., Tucker, M. H., & Macy, E. M. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0854-6 · Cited by 97
Infective Endocarditis: Prevention, Diagnosis, and Management
Thuny, F., Grisoli, D., Cautela, J., Ribéri, A., Raoult, D., & Habib, G. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.03.042 · Cited by 103
Identifying low-risk beta-lactam allergy patients in a UK tertiary centre.
Siew, L. Q. C., Li, P. H., Watts, T. J., Thomas, I., Ue, K. L., Caballero, M. R., Rutkowski, K., Till, S. J., Pillai, P., & Haque, R. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.015 · Cited by 89
Who needs penicillin allergy testing?
Macy, E., & Vyles, D. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.07.041 · Cited by 76
3rd GUIDELINE FOR PERIOPERATIVE CARDIOVASCULAR EVALUATION OF THE BRAZILIAN SOCIETY OF CARDIOLOGY
Gualandro, D., Yu, P., Caramelli, B., Marques, A., Calderaro, D., Fornari, L. S., Pinho, C., Feitosa, A. K. N., Polanczyk, C. A., Rochitte, C. E., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170140 · Cited by 90
The Cost-Effectiveness of Antibiotic Prophylaxis for Patients at Risk of Infective Endocarditis
Franklin, M. K., Wailoo, A., Dayer, M., Jones, S., Prendergast, B., Baddour, L. M., Lockhart, P. B., & Thornhill, M. H. (2016) · Circulation · doi:10.1161/circulationaha.116.022047 · Cited by 85
Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
Oliver, R., ROBERTS, G. J., Hooper, L., & Worthington, H. V. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003813.pub3 · Cited by 83
Jeimy, S. B., Ben‐Shoshan, M., Abrams, E. M., Ellis, A. K., Connors, L. A., & Wong, T. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00494-2 · Cited by 87
Infective endocarditis and oral health—a Narrative Review
Bumm, C. V., & Folwaczny, M. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-908 · Cited by 83
“In fact, considering the data regarding ADRs (59,60) and data published by Dayer et al.”
BackgroundGuidelines on prophylaxis to prevent infective endocarditis
Thornhill, M. H., Dayer, M., Lockhart, P. B., McGurk, M., Shanson, D. C., Prendergast, B., & Chambers, J. B. (2016) · BDJ · doi:10.1038/sj.bdj.2016.49 · Cited by 71
Self-citationLiang, E. H., Chen, L. H., & Macy, E. M. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.11.035 · Cited by 61
Moral, L., & Caubet, J. (2017) · Pediatric Allergy and Immunology · doi:10.1111/pai.12800 · Cited by 51
Antibiotic prophylaxis for dental procedures
Daly, C. G. (2017) · Australian Prescriber · doi:10.18773/austprescr.2017.054 · Cited by 62
Changing patterns in the epidemiology of drug allergy
Doña, I., Torres, M. J., Çelík, G., Phillips, E. J., Tanno, L. K., & Castells, M. (2023) · Allergy · doi:10.1111/all.15970 · Cited by 54
Blanca‐López, N., Atanasković‐Marković, M., Gomes, E. R., Kidon, M. I., Kuyucu, S., Mori, F., Soyer, Ö., & Caubet, J. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13529 · Cited by 47
NICE and antibiotic prophylaxis to prevent endocarditis
Thornhill, M. H., Lockhart, P. B., Prendergast, B., Chambers, J. B., & Shanson, D. C. (2015) · BDJ · doi:10.1038/sj.bdj.2015.496 · Cited by 48
Self-citationShanson, D. C. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f94765 · Cited by 40
Self-citationIammatteo, M., Lezmi, G., Confino‐Cohen, R., Tucker, M. H., Ben‐Shoshan, M., & Caubet, J. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.073 · Cited by 41
Antibiotic prophylaxis of endocarditis: the rest of the world and NICE
Chambers, J. B., Shanson, D. C., Hall, R. J. C., Pepper, J., Venn, G. E., & McGurk, M. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2011.100356 · Cited by 46
Self-citationSelf-reported beta-lactam intolerance: not a class effect, dangerous to patients, and rarely allergy
Vyles, D. E., & Macy, E. M. (2019) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1617132 · Cited by 41
Salvo, F., Polimeni, G., Cutroneo, P. M., LEONE, R., CONFORTIC, A., Moretti, U., Motola, D., Tuccori, M., & Caputi, A. P. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.07.003 · Cited by 40
Kuder, M. M., Lennox, M. G., Li, M., Lang, D. M., & Pien, L. C. (2020) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2020.08.012 · Cited by 35
Outpatient penicillin allergy evaluation during pregnancy and associated clinical outcomes
Kwah, J. H., Burn, M. S., Liao, J., Cate, J. J. M., & Son, M. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100674 · Cited by 36
Cummins, J., McCarthy, M., Esterman, A., Karve, A., & Lee, A. (2019) · Journal of Evidence Based Dental Practice · doi:10.1016/j.jebdp.2019.01.007 · Cited by 34
Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics
Minaldi, E., Phillips, E. J., & Norton, A. E. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08903-z · Cited by 37
“001% and more significant with parenteral administration [21, 22].”
BackgroundRecommendations for the Management of Beta-Lactam Intolerance
Macy, E. M., & Ngor, E. W. M. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-013-8369-8 · Cited by 29
“Death from anaphylaxis associated with oral beta-lactam use is extremely rare [4].”
Fetters, T., Rubayet, S., Sultana, S., Nahar, S., Tofigh, S., Jones, L., Samandari, G., & Powell, B. (2020) · Conflict and Health · doi:10.1186/s13031-020-00298-6 · Cited by 22
Moving Toward Optimizing Testing for Penicillin Allergy
Aberer, W., & Macy, E. M. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.03.020 · Cited by 26
“The risk of causing death with an oral amoxicillin exposure is also known to be extremely low, with no fatalities noted in more than 100,000,000 oral amoxicillin courses given in Great Britain over a 35-year period.(13) At Kaiser Permanente in San Diego, we currently recommend a direct oral amoxicillin 250 mg challeng…”
BackgroundEndocarditis prevention: time for a review of NICE guidance
Thornhill, M. H., Prendergast, B., Dayer, M., Frisby, A., & Baddour, L. M. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.100876 · Cited by 27
“46 The NICE estimate of 20 fatal ADRs/million prescriptions 12,47 relied on data from 1968 48 and 1984, 49 while the non-fatal ADR rate of 20,000/million prescriptions was derived from a 1997 estimate, 47,50 leading them to conclude that “ antibiotic prophylaxis against IE for dental procedures may…”
BackgroundControversies in Allergy: Is Skin Testing Required Prior to Drug Challenges?
Macy, E. M., & Ensina, L. F. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.09.008 · Cited by 23
Danilkowicz, R. M., Lachiewicz, A. M., Lorenzana, D. J., Barton, K. D., & Lachiewicz, P. F. (2021) · Arthroplasty Today · doi:10.1016/j.artd.2020.11.007 · Cited by 18
“Conversely, few serious adverse reactions and almost no deaths would be expected with single prophylactic dose of amoxicillin [52,65].”
InfluentialShould testing be initiated prior to amoxicillin challenge in children?
Abrams, E. M., & Ben‐Shoshan, M. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13443 · Cited by 20
Update on penicillin allergy delabeling
Shaker, M. S., McWilliams, S., & Greenhawt, M. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000879 · Cited by 18
Guía ESC 2015 sobre el tratamiento de la endocarditis infecciosa
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.11.015 · Cited by 54
Cloître, A., Duval, X., Tubiana, S., Giraud, P., Veyrac, G., Nosbaum, A., Gouraud, A., Mahé, J., & Lesclous, P. (2019) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22818 · Cited by 20
“latory Agency (MHRA) database, Lee and Shanson reported no fatal cases with the single 3 g oral dose of amoxicillin in the UK between February 1972 and May 2007 (8).”
BackgroundDiagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019*
Yavuz, S. Ş., Akar, A. R., Aydoğdu, S., Deniz, D. B., Demir, H., Hazırolan, T., Ozatik, M. A., Özer, N., Sargın, M., Topçuoğlu, N., et al. (2020) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2020.89689 · Cited by 25
Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology – 2024
Gualandro, D. M., Fornari, L. S., Caramelli, B., Abizaid, A., Gomes, B. R., Tavares, C. A. M., Fernandes, C. J. C. D. S., Polanczyk, C. A., Jardim, C., Vieira, C. L. Z., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240590i · Cited by 14
Moral, L., Toral, T., Muñoz, C., Marco, N., García‐Avilés, B., Murcia, L., Forniés, M. J., González, M. C., Canals, F., Bragado, E., et al. (2024) · Pediatric Allergy and Immunology · doi:10.1111/pai.14096 · Cited by 13
Risk Stratification and Prediction in Beta-Lactam Allergic Patients
Ramsey, A. C., Caubet, J., & Blumenthal, K. G. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.045 · Cited by 13
Diretriz de Avaliação Cardiovascular Perioperatória da Sociedade Brasileira de Cardiologia – 2024
Gualandro, D. M., Fornari, L. S., Caramelli, B., Abizaid, A., Gomes, B. R., Tavares, C. A. M., Fernandes, C. J. C. D. S., Polanczyk, C. A., Jardim, C., Vieira, C. L. Z., et al. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240590 · Cited by 43
New evidence calls into question NICE's endocarditis prevention guidance
Thornhill, M. H., Prendergast, B., Dayer, M., Frisby, A., Lockhart, P. B., & Baddour, L. M. (2024) · BDJ · doi:10.1038/s41415-024-7344-5 · Cited by 12
“33 The NICE ADR estimates therefore significantly overestimated the ADR risk posed by amoxicillin AP used for IE prevention.”
BackgroundYavuz, S. Ş., Akar, A., Aydoğdu, S., Berzeg-Deniz, D., Demir, H., Hazırolan, T., Özatık, M. A., Özer, N., Sarğın, M., Topçuoğlu, N., et al. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 13
Ampicillin, Amoxicillin and Other Ampicillin-Like Penicillins
Geddes, A. M., & Gould, I. M. (2010) · CRC Press eBooks · doi:10.1201/b13787-6 · Cited by 10
The rationale for the new infective endocarditis guidelines
Bolger, A. F. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0016-x · Cited by 10
“Finally, the amount of risk attributable to antibiotic exposure is very slight, especially with respect to anaphylaxis [25, 26 ].”
BackgroundAntibiotic prophylaxis of endocarditis: a NICE mess
Chambers, J. B., Thornhill, M. H., Shanson, D. C., & Prendergast, B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00048-7 · Cited by 8
“3 there have there been no reports in the world literature of fatal anaphylaxis after oral amoxicillin prophylaxis for IE (4,5).”
BackgroundSelf-citationAntibiotic oral provocation challenge in children
Guðnadóttir, G. K., Jónasson, G., Clausen, M. V., Sørensen, T. G., & Kristjánsson, S. (2021) · Acta Paediatrica · doi:10.1111/apa.16211 · Cited by 8
Shanson, D. C. (2010) · International Health · doi:10.1016/j.inhe.2010.09.001 · Cited by 9
Self-citationAnaphylaxis to Drugs, Biological Agents, and Vaccines
Shah, R., Kuder, M. M., & Lang, D. M. (2021) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.10.001 · Cited by 9
Shanson, D. C. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e328303e6e3 · Cited by 8
Self-citationBosmans, T., Melis, S. M., de Rooster, H., Goethem, B. V., Defauw, P., Soens, I. V., & Polis, I. (2014) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.v83i1.16671 · Cited by 6
Wang, Y., Xiang, Y., Liao, O., Wu, Y., Li, Y., Du, Q., & Ye, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062096 · Cited by 5
Meyer, B. I., Berry, D. E., Cribbs, B. E., Hendrick, A. M., Jain, N., Hubbard, G. B., O’Keefe, G. A. D., Patel, P. S., Shantha, J. G., Yan, J., et al. (2020) · Ophthalmology Retina · doi:10.1016/j.oret.2020.11.015 · Cited by 6
A critical appraisal of acute sore throat guidelines using the AGREE II instrument: a scoping review
Supper, I., Gratadour, J., François, M., Jaafari, N., & Boussageon, R. (2023) · Family Practice · doi:10.1093/fampra/cmad060 · Cited by 6
Jankelow, D., Cupido, B. J., Zuhlke, L. J., Sliwa, K. S., Ntsekhe, M., Manga, P., Doubell, A. F., Lawrenson, J., & Essop, M. R. (2017) · SA Heart · doi:10.24170/14-3-2716 · Cited by 5
Penicillin-Allergie – tödliche „Fake News“ in der Krankenakte?
Schulz-Stübner, S. (2020) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-1099-2902 · Cited by 4
“Merke Tatsächliches versus gefühltes Risiko: Von 100 Millionen exponierten Patienten im Vereinigten Königreich starb nur ein einziger im Zeitraum von 1972–2007 an einem anaphylaktischen Schock nach oraler Einnahme von Amoxicillin [16].”
BackgroundInfluentialBelmont, A. P., Novotny, S., Mukherjee, E. M., Park, D., Wong, K. H., Martin-Pozo, M. D., Phillips, E. J., & Stone, C. A. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.07.039 · Cited by 3
Urriola, N., Paganini, L., Riminton, S., & Limaye, S. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.01.014 · Cited by 3
Penicillin and Cephalosporin-Induced Anaphylaxis: an Update
Doña, I., Bogas, G., Pérez‐Sánchez, N., Fernández, T. D., Moreno, E., & Torres, M. J. (2018) · Current Treatment Options in Allergy · doi:10.1007/s40521-018-0172-6 · Cited by 3
Inaccurate Penicillin Allergy Labeling, the Electronic Health Record, and Adverse Outcomes of Care
Olans, R. D., Olans, R. N., Marfatia, R., & Angoff, G. H. (2022) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2022.06.009 · Cited by 4
Fatal ampicillin-sulbactam anaphylaxis in a 34-year-old male
Young, M. C., Lemoine, C., Accarino, J. J. O., Nelson, S. B., Crowley, J., & Blumenthal, K. G. (2023) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2023.100136 · Cited by 3
“In the United Kingdom, only 1 fatal amoxicillin reaction was reported over a 35-year period.(3) Ampicillin and amoxicillin are aminopenicillins, defined as 2amino derivatives of benzylpenicillin.”
BackgroundPenicillin Allergy Evaluations: An Emerging Component of Comprehensive Cancer Care
Ramsey, A. C., & Staicu, M. L. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.018 · Cited by 3
Fatal anaphylaxis to intravenous co-amoxiclav: A case series
Conlon, N. P., & Edgar, J. (2013) · International Journal of Case Reports and Images · doi:10.5348/ijcri-2013-04-292-cs-1 · Cited by 2
“Deaths from such reactions are considered rare [3].”
BackgroundUnnecessary Antibiotic Prescribing in Dental Practices and Associated Adverse Effects
Gross, A. E., Khouja, T., Rowan, S. A., & Suda, K. J. (2021) · Current Infectious Disease Reports · doi:10.1007/s11908-021-00751-4 · Cited by 5
Beaulieu, R. G. (2009) · Paediatrics & Child Health · doi:10.1093/pch/14.3.173 · Cited by 2
“Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin.”
BackgroundInfluentialAmoxicillin prophylaxis is not associated with anaphylaxis
Friedlander, A. H. (2010) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2010.01.020 · Cited by 2
Jones, M. L., & Foley, M. R. (2018) · Wiley eBooks · doi:10.1002/9781119072980.ch26 · Cited by 2
Pakravan, F., Jabbari, B., Isfahani, M. N., Tabesh, A., & Jabbari, L. (2025) · BMC Research Notes · doi:10.1186/s13104-025-07296-y · Cited by 2
“Fatal anaphylactic reactions have occurred with high oral doses of amoxicillin [19, 20].”
Endocarditis Prophylaxis—Indications, Application and Current Controversies
Thornhill, M. H., Dayer, M., Prendergast, B., & Baddour, L. M. (2025) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2025.10.011 · Cited by 3
Woodward, K. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735483-00273 · Cited by 1
Management of Children with Reported Penicillin Allergies
Zembles, T. N., Vyles, D. E., & Mitchell, M. L. (2022) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.11.001 · Cited by 2
Implementing Preoperative Penicillin Allergy Testing in Surgical Patients
Gupta, R. A., Lee, H., & Okocha, O. (2023) · A&A Practice · doi:10.1213/xaa.0000000000001659 · Cited by 1
Infective endocarditis of presumed dental origin and the new NICE guidelines: a case report
Rico, A. D. G., Williams, J. V., Ranjadayalan, K., & Revington, P. J. (2012) · Oral Surgery · doi:10.1111/j.1752-248x.2012.01155.x · Cited by 1
Penicillin-Allergie – tödliche „Fake News“ in der Krankenakte?
Schulz-Stübner, S. (2019) · Krankenhaushygiene up2date · doi:10.1055/a-0959-3078 · Cited by 1
“A Amoxicillin B Ampicillin C Piperacillin D Cefaclor E Cefazolin 339”
BackgroundInfluentialPrévention des endocardites : où en est-on ?
Fierobe, L. (2010) · Le Praticien en Anesthésie Réanimation · doi:10.1016/j.pratan.2010.04.001
A response to “Amoxicillin prophylaxis is not associated with anaphylaxis”
Farbod, F. (2010) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2010.01.019
Shanson, D. C. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn536
Self-citationBosmans, T., Melis, S. M., de Rooster, H., Goethem, B. V., Defauw, P., Soens, I. V., Polis, I., & Diergeneeskunde, F. (2014)
Hancocks, S. (2015) · BDJ · doi:10.1038/sj.bdj.2015.392 · Cited by 1
Infective Endocarditis Prophylaxis and Prevention
Duval, X. (2016) · Springer eBooks · doi:10.1007/978-3-319-32432-6_23 · Cited by 1
Antibiotic prophylaxis of endocarditis: a NICE mess
Saunders, D., Lon, C., & Detrick, F. (2016)
Macy, E. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48551-7.00010-9
Penicillin-Allergie – tödliche „Fake News“ in der Krankenakte?
Schulz-Stübner, S. (2020) · Intensivmedizin up2date · doi:10.1055/a-1157-5322
Assessment of Nurses Performance Regarding Penicillin Administration for Pediatric Patients
Mosbeh, A. N. E., Tantawi, H. R., & Ali, N. S. M. (2021) · Egyptian Journal of Health Care · doi:10.21608/ejhc.2021.183451
Current awareness: Pharmacoepidemiology and drug safety
(2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1487
Current awareness: Pharmacoepidemiology and drug safety
(2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1368
Shanson, D. C. (2008) · BDJ · doi:10.1038/sj.bdj.2008.511
Self-citationPenicillin-Allergie – tödliche „Fake News“ in der Krankenakte?
Schulz-Stübner, S. (2022) · Zahnmedizin up2date · doi:10.1055/a-1884-2993
Metadata
- Authors
- Lee, P., & Shanson, D.
- Affiliations
- Medicines and Healthcare products Regulatory Agency (GB)
- Great Ormond Street Hospital (GB)
- Corresponding author
- Lee, P.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-17
- Volume
- 60
- Issue
- 5
- Pages
- 1172-1173
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2127114574
- Cited by
- 104
- References
- 6
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 9 · 2019: 13 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 2
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- fatal anaphylaxis, oral amoxicillin, antibiotic prophylaxis, infective endocarditis, adverse drug reactions, Yellow Card Scheme, risk-benefit assessment, dental treatment, pharmacovigilance, NICE guidelines
- MeSH terms
- Administration, Oral, Adult, Amoxicillin, Anaphylaxis, Anti-Bacterial Agents, Child, Data Collection, Endocarditis, Bacterial, United Kingdom, Humans, Risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.